Indeed, the genome of Patient 1 had yet another heterozygous substitution, Trp16Ser [rs6185], in GnRH1. This variant was previously reported as polymorphism examined for its minor Ser16 allele association with decreased bone mineral density [9] and shorter disease-free survival in breast cancer patients [10]. This evidence concerns the gene GNRH1 and breast cancer.